Although smoking was identified two decades ago as a factor promoting the o
nset and progression of nephropathy in Type 1 and then in Type 2 diabetes,
its role has been largely neglected. More recently, it has been shown that
smoking adversely affects renal haemodynamics and protein excretion even in
subjects without renal disease. In addition, it impairs the prognosis for
renal function in patients with nondiabetic renal disease. Recent studies h
ave suggested the involvement of sympathetic activation, increased endothel
in production, and impaired endothelial cell-dependent vasodilatation in th
e genesis of smoking-induced renal function impairement. Cessation of smoki
ng apparently slows progression to renal failure, but the decision to stop
smoking is difficult because of the high addictive potential of the habit.
The challenge remains for diabetologists and nephrologists to motivate pati
ents to stop smoking.